
|Articles|March 18, 2006
Novel anti-collagenolytic regimen applied for treating stage IV DLK
A new treatment strategy consisting of oral doxycycline and topical sodium citrate 10% may have a positive role in the treatment of post-LASIK inflammatory conditions characterized by increased collagenolytic activities, said Elias F. Jarade, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Development of maculopathy associated with systemic medications
2
Evolving glaucoma therapy: A new era of interventional strategies
3
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
4
Proactive strategies and sustained delivery advance glaucoma care
5

















































.png)


